SDC4, syndecan 4, 6385

N. diseases: 71; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0029408
Disease: Degenerative polyarthritis
Degenerative polyarthritis
0.040 AlteredExpression disease BEFREE This study revealed that the cartilage protective effect of osthole in a MIA-induced osteoarthritis (OA) murine model can be explained by downregulation of COX-2 and RUNX2 by inhibition of NF-κB and HIF-2α up-regulated by OA induction, resulting in downregulation of MMP-13, Syndecan IV and ADAMTS-5. 31765607 2020
CUI: C0029408
Disease: Degenerative polyarthritis
Degenerative polyarthritis
0.040 Biomarker disease BEFREE Using an immunoassay for the extracellular domain of syndecan-4, we found 68% of the syndecan-4 in the culture supernatant of OA chondrocytes culture, suggesting that a large majority of the syndecan-4 is shed and released in the extracellular medium. 31455087 2019
CUI: C0029408
Disease: Degenerative polyarthritis
Degenerative polyarthritis
0.040 AlteredExpression disease BEFREE Both VEGF and syndecan-4 are expressed by chondrocytes and both are involved in the regulation of matrix metalloproteinase-3, resulting in the activation of aggrecanase II (ADAMTS-5), which is essential in the pathogenesis of OA. 25274915 2014
CUI: C0029408
Disease: Degenerative polyarthritis
Degenerative polyarthritis
0.040 Biomarker disease BEFREE Our data suggest that strategies aimed at the inhibition of syndecan-4 will be of great value for the treatment of cartilage damage in osteoarthritis. 19684582 2009